# A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

> **NCT04903873** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Eutilex** · enrollment: 110 (estimated)

## Conditions studied

- Solid Tumor
- Renal Cell Cancer Metastatic
- Non-Small Cell Lung Cancer
- Renal Cell Carcinoma
- Prostate Cancer

## Interventions

- **DRUG:** EU101

## Key facts

- **NCT ID:** NCT04903873
- **Lead sponsor:** Eutilex
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-31
- **Primary completion:** 2025-09
- **Final completion:** 2025-12
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2024-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04903873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04903873, "A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04903873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*